|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| C07K 16/00 | (2006.01) | ||
| A61K 47/65 | (2017.08) | ||
| A61K 47/6889 | (2017.08) | ||
| A61K 47/68 | (2017.01) | ||
| A61K 47/6803 | (2017.08) | ||
| A61K 47/65 | (2017.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61K 47/6835 | (2017.08) | ||
| A61P 25/00 | (2006.01) | ||
| C07K 16/00 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| C07K2319/50 | (2013.01) | ||
| A61P 31/00 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 33/00 | (2006.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 33/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Patento numeris | 3628328 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19194203.6 |
| Europos patento paraiškos padavimo data | 2015-01-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-09-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201461934619 P | 2014-01-31 | US | |
| 201461971009 P | 2014-03-27 | US |
| (72) |
MOORE, Stephen James , US
NGUYEN, Margaret Thy Luu , US
HOSTETTER, Daniel R. , US
VASILJEVA, Olga , US
|
| (73) |
Cytomx Therapeutics Inc. ,
151 Oyster Point Boulevard, Suite 400, South San Francisco, CA 94080,
US
|
| (54) | MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF |
| MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF |